NovaSterilis, located in Ithaca, NY, is a company focused on supporting regenerative medicine manufacturers by processing (e.g., cleaning, sterilizing, impregnating, and improving) materials with supercritical carbon dioxide.

Over the last 10 years, Cal Poly has provided well-trained graduates for the Regenerative Medicine Industry through a Regenerative Medicine Interdisciplinary Program that integrates students and faculty from Biomedical Engineering, Biological Sciences, and Animal Science.

Scientists have taken a major step closer to being able to 3D bioprint functional organs by devising a method of rebuilding components of the human heart. FluidForm, a new ARMI member, is making this technology available for research and commercial applications, with the ultimate goal to revolutionize regenerative medicine and impact millions of Americans every year.

Progenesis Technologies LLC, a Huntington, WV bio-engineering company, says producing customized molecular scaffolds from alginate products has a “fundamental advantage over seaweed derived alginates in cost efficiencies and customization for various applications,” according to Gardiner F.H. Smith, Executive Chairman.

CAST, a nonprofit organization headquartered in Wakefield, MA, believes learning should have no limits. Founded in 1984, by education researchers, CAST created the Universal Design for Learning (UDL) framework, a set of principles based on learning sciences including neuropsychology, human development, and education research.

Xylyx Bio spun out of Columbia University’s renowned Laboratory for Stem Cell and Tissue Engineering in 2016 to commercialize matrix bioactives for tissue regeneration and complete cell health.

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions in sport medicine and severe burn cases and is a leader in the development of autologous cell therapies to repair or restore damaged tissues or organs.

Pluristyx was established in 2018 with the goal of solving challenges associated with cell manufacturing by manufacturing GMP grade pluripotent stem cells at large scale for use as a universal starting material for the further manufacturing of therapeutic regenerative medicine products. 

RoosterBio was founded in 2013 to specifically address the industry-wide bottleneck that is the scarcity of high quality and scalable cellular starting materials for product development and clinical manufacturing, is a pioneer in Regenerative Medicine (RM) manufacturing, with a focus on human mesenchymal stem/stromal cells (hMSC) raw materials, bioprocess design, and production technologies.